BDKRB1 and diabetes mellitus: Together with previous studies documenting cardioprotective effect of the B1R agonist in the diabetic and ischemic mouse heart11 and proangiogenic effect in peripheral ischemia in diabetic mice12, the present observations argue for clinical development of kinin B1R agonist for cardiovascular and cerebral protection in diabetes.